Pages with the most categories
Jump to navigation
Jump to search
Showing below up to 50 results in range #1 to #50.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Cyclophosphamide (Cytoxan) (62 categories)
- Cisplatin (Platinol) (60 categories)
- Etoposide (Vepesid) (57 categories)
- Doxorubicin (Adriamycin) (56 categories)
- Vincristine (Oncovin) (56 categories)
- Methotrexate (MTX) (50 categories)
- Gemcitabine (Gemzar) (45 categories)
- Carboplatin (Paraplatin) (44 categories)
- Prednisone (Sterapred) (43 categories)
- Pembrolizumab (Keytruda) (41 categories)
- Paclitaxel (Taxol) (40 categories)
- Bevacizumab (Avastin) (35 categories)
- Rituximab (Rituxan) (35 categories)
- Docetaxel (Taxotere) (34 categories)
- Fluorouracil (5-FU) (34 categories)
- Dexamethasone (Decadron) (34 categories)
- Cytarabine (Ara-C) (33 categories)
- External beam radiotherapy (33 categories)
- Nivolumab (Opdivo) (32 categories)
- Lenalidomide (Revlimid) (31 categories)
- Rituximab-abbs (Truxima) (31 categories)
- Rituximab-arrx (Riabni) (31 categories)
- Rituximab-pvvr (Ruxience) (31 categories)
- Ifosfamide (Ifex) (30 categories)
- Bevacizumab-maly (Alymsys) (28 categories)
- Fludarabine (Fludara) (28 categories)
- Bevacizumab-adcd (Vegzelga) (28 categories)
- Bevacizumab-awwb (Mvasi) (28 categories)
- Bevacizumab-bvzr (Zirabev) (28 categories)
- Bendamustine (27 categories)
- Irinotecan (Camptosar) (27 categories)
- Oxaliplatin (Eloxatin) (27 categories)
- Bleomycin (Blenoxane) (27 categories)
- Melphalan (Alkeran) (26 categories)
- Cabozantinib (Cometriq) (25 categories)
- Sunitinib (Sutent) (25 categories)
- Sorafenib (Nexavar) (25 categories)
- Epirubicin (Ellence) (25 categories)
- Temozolomide (Temodar) (24 categories)
- Everolimus (Afinitor) (24 categories)
- Prednisolone (Millipred) (24 categories)
- Vinblastine (Velban) (24 categories)
- Capecitabine (Xeloda) (24 categories)
- Pegylated liposomal doxorubicin (Doxil) (24 categories)
- Atezolizumab (Tecentriq) (23 categories)
- Regorafenib (Stivarga) (23 categories)
- Erlotinib (Tarceva) (23 categories)
- Ipilimumab (Yervoy) (22 categories)
- Busulfan (Myleran) (22 categories)
- Vemurafenib (Zelboraf) (21 categories)